| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Cellular senescence and inhibitory effects of PRIMA-1MET in cholangiocarcinoma | Chayanit Piyawajanusorn Watcharin Loilome Yingpinyapat Kittirat Suyanee Thongchot Nisana Namwat |
2018 | ||||
| 2. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine | Techasen, A. Thongchot, S. Loilome, W. Thanan, R. Yongvanit, P. Titapun, A. Khuntikeo, N. Namwat, N. |
2018 | ||||
| 3. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 | ||||
| 4. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 | ||||
| 5. | PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. | Piyawajanusorn, C Kittirat, Y Sa-Ngiamwibool, P Titapun, A Loilome, W Namwat, N |
2019 | ||||
| 6. | PRIMA-1MET induces cellular senescence and apoptotic cell death in cholangiocarcinoma cells | Chayanit Piyawajanusorn Yingpinyapat Kittirat Prakasit Sa-Ngiamwibool Attapol Titapun Watcharin Loilome Nisana Namwat |
2019 | ||||
| 7. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M Dokduang, H Kittirat, Y Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Khuntikeo, N Wangwiwatsin, A Saya, H Loilome, W |
2021 | ||||
| 8. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 | ||||
| 9. | Metabolic changes of cholangiocarcinoma cells in response to coniferyl alcohol treatment | Bundit Promraksa Praewpan Katrun Jutarop Phetcharaburanin Yingpinyapat Kittirat Nisana Namwat Anchalee Techasen Jia V. Li Watcharin Loilome |
2021 | ||||
| 10. | Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. | Prommajun, P Phetcharaburanin, J Namwat, N Klanrit, P Sa-Ngiamwibool, P Thanee, M Dokduang, H Kittirat, Y Li, JV Loilome, W |
2021 | ||||
| 11. | Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma | Pattama Prommajun Jutarop Phetcharaburanin Nisana Namwat Poramate Klanrit Prakasit Sa-Ngiamwibool Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jia Li Watcharin Loilome |
2021 | ||||
| 12. | Application of Urine and Copro Antigen Assays after Primary Infection and Drug Treatment in an Experimental Opisthorchiasis Animal Model. | Worasith, C Kopolrat, KY Pitaksakulrat, O Homwong, C Kittirat, Y Wongphutorn, P Sithithaworn, J Sithithaworn, P |
2022 | ||||
| 13. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 | ||||
| 14. | Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. | Kulthawatsiri, T Kittirat, Y Phetcharaburanin, J Tomacha, J Promraksa, B Wangwiwatsin, A Klanrit, P Titapun, A Loilome, W Namwat, N |
2023 | ||||
| 15. | Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis. | Thongchot, S Ferraresi, A Vidoni, C Salwa, A Vallino, L Kittirat, Y Loilome, W Namwat, N Isidoro, C |
2023 | ||||
| 16. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 | ||||
| 17. | Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. | Islam, K Balasubramanian, B Venkatraman, S Thummarati, P Tunganuntarat, J Phueakphud, N Kanjanasirirat, P Khumpanied, T Kongpracha, P Kittirat, Y Tohtong, R Janvilisri, T Wongtrakoongate, P Borwornpinyo, S Namwat, N Suthiphongchai, T |
2023 | Count | 8 | 11 | 7 | 0 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Total | ||||||
| 1. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine | Techasen, A. Thongchot, S. Loilome, W. Thanan, R. Yongvanit, P. Titapun, A. Khuntikeo, N. Namwat, N. |
2018 |
Oncology Letters 1 (15), pp. 347-353 |
||||||||
| 2. | PRIMA-1MET induces cellular senescence and apoptotic cell death in cholangiocarcinoma cells | Titapun, A. Loilome, |
2019 |
Cancer Genomics and Proteomics 6 (16), pp. 543-552 |
||||||||
| 3. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 |
PLoS ONE 3 March (16), pp. |
||||||||
| 4. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 |
Frontiers in Public Health (9), pp. |
||||||||
| 5. | Metabolic changes of cholangiocarcinoma cells in response to coniferyl alcohol treatment | Promraksa, B. Katrun, P. Phetcharaburanin, J. Namwat, N. Techasen, A. Loilome, W. |
2021 |
Biomolecules 3 (11), pp. 1-15 |
||||||||
| 6. | Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma | Phetcharaburanin, J. Namwat, N. Klanrit, P. Thanee, M. Dokduang, H. Loilome, W. |
2021 |
Cancer Genomics and Proteomics 1 (18), pp. 29-42 |
||||||||
| 7. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 |
Frontiers in Pharmacology (13), pp. |
||||||||
| 8. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 |
Scientific Reports 1 (13), pp. |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 |
Oncology letters 1 (15), pp. 347-353 |
|
| 2. | PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. | Piyawajanusorn, C Kittirat, Y Sa-Ngiamwibool, P Titapun, A Loilome, W Namwat, N |
2019 |
Cancer genomics & proteomics 6 (16), pp. 543-552 |
|
| 3. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression. | Thanee, M Dokduang, H Kittirat, Y Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Khuntikeo, N Wangwiwatsin, A Saya, H Loilome, W |
2021 |
PloS one 3 (16), pp. e0245871 |
|
| 4. | Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. | Prommajun, P Phetcharaburanin, J Namwat, N Klanrit, P Sa-Ngiamwibool, P Thanee, M Dokduang, H Kittirat, Y Li, JV Loilome, W |
2021 |
Cancer genomics & proteomics 1 (18), pp. 29-42 |
|
| 5. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 |
Frontiers in public health (9), pp. 766455 |
|
| 6. | Application of Urine and Copro Antigen Assays after Primary Infection and Drug Treatment in an Experimental Opisthorchiasis Animal Model. | Worasith, C Kopolrat, KY Pitaksakulrat, O Homwong, C Kittirat, Y Wongphutorn, P Sithithaworn, J Sithithaworn, P |
2022 |
The American journal of tropical medicine and hygiene 5 (106), pp. 1470-7 |
|
| 7. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 |
Frontiers in pharmacology (13), pp. 897368 |
|
| 8. | Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis. | Thongchot, S Ferraresi, A Vidoni, C Salwa, A Vallino, L Kittirat, Y Loilome, W Namwat, N Isidoro, C |
2023 |
Cancer letters (582), pp. 216589 |
|
| 9. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. | Phukhum, P Phetcharaburanin, J Chaleekarn, K Kittirat, Y Kulthawatsiri, T Namwat, N Loilome, W Khuntikeo, N Titapun, A Wangwiwatsin, A Khampitak, T Suksawat, M Klanrit, P |
2023 |
Scientific reports 1 (13), pp. 3072 |
|
| 10. | Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. | Kulthawatsiri, T Kittirat, Y Phetcharaburanin, J Tomacha, J Promraksa, B Wangwiwatsin, A Klanrit, P Titapun, A Loilome, W Namwat, N |
2023 |
PeerJ (11), pp. e16512 |
|
| 11. | Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells. | Islam, K Balasubramanian, B Venkatraman, S Thummarati, P Tunganuntarat, J Phueakphud, N Kanjanasirirat, P Khumpanied, T Kongpracha, P Kittirat, Y Tohtong, R Janvilisri, T Wongtrakoongate, P Borwornpinyo, S Namwat, N Suthiphongchai, T |
2023 |
Scientific reports 1 (13), pp. 22598 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Total | ||||||
| 1. | Cellular senescence and inhibitory effects of PRIMA-1MET in cholangiocarcinoma | Chayanit Piyawajanusorn Watcharin Loilome Yingpinyapat Kittirat Suyanee Thongchot Nisana Namwat |
2018 |
CANCER SCIENCE (109.0), pp. 1382.0-1382.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 2. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 |
ONCOLOGY LETTERS 1.0 (15.0), pp. 347.0-353.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 3. | PRIMA-1(MET) Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells | Chayanit Piyawajanusorn Yingpinyapat Kittirat Prakasit Sa-Ngiamwibool Attapol Titapun Watcharin Loilome Nisana Namwat |
2019 |
CANCER GENOMICS & PROTEOMICS 6.0 (16.0), pp. 543.0-552.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 4. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Narong Khuntikeo Arporn Wangwiwatsin Hideyuki Saya Watcharin Loilome |
2021 |
PLOS ONE 3.0 (16.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Yingpinyapat Kittirat Jutarop Phetcharaburanin Bundit Promraksa Thanaporn Kulthawatsiri Arporn Wangwiwatsin Poramate Klanrit Sakkarn Sangkhamanon Apiwat Jarearnrat Suyanee Thongchot Panupong Mahalapbutr Watcharin Loilome Hideyuki Saya Nisana Namwat |
2021 |
FRONTIERS IN PUBLIC HEALTH (9.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | Metabolic Changes of Cholangiocarcinoma Cells in Response to Coniferyl Alcohol Treatment | Bundit Promraksa Praewpan Katrun Jutarop Phetcharaburanin Yingpinyapat Kittirat Nisana Namwat Anchalee Techasen Jia V. Li Watcharin Loilome |
2021 |
BIOMOLECULES 3.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma | Pattama Prommajun Jutarop Phetcharaburanin Nisana Namwat Poramate Klanrit Prakasit Sa-Ngiamwibool Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jia Li Watcharin Loilome |
2021 |
CANCER GENOMICS & PROTEOMICS 1.0 (18.0), pp. 29.0-42.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title |
|---|
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|